CIPHER PHARMACEUTICALS INC Profit Climbs In Q3, Beats Estimates

Published 3 days ago Positive
CIPHER PHARMACEUTICALS INC Profit Climbs In Q3, Beats Estimates
(RTTNews) - CIPHER PHARMACEUTICALS INC (CPH.TO) revealed earnings for its third quarter that Increased, from last year and beat the Street estimates.

The company's earnings totaled $5.50 million, or $0.21 per share. This compares with $0.283 million, or $0.01 per share, last year.

Analysts on average had expected the company to earn $0.17 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 23.7% to $12.83 million from $10.37 million last year.

CIPHER PHARMACEUTICALS INC earnings at a glance (GAAP) :

-Earnings: $5.50 Mln. vs. $0.283 Mln. last year. -EPS: $0.21 vs. $0.01 last year. -Revenue: $12.83 Mln vs. $10.37 Mln last year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.